Search NASA⌕ Search

Engineering topics

Schaffer, David

Publications and source records attributed to Schaffer, David.

Engineering the AAV capsid to evade immune responses

Gene therapy is progressively emerging as a promising and powerful therapeutic modality, and adeno-associated virus (AAV) is a major delivery vehicle for such therapies. Among the most significant challenges that limit AAV's utility, however, is the immune response it elicits. Antibodies elicited by prior exposure to natural virus or vector can bind to an AAV vector, preventing it from entering the cell. Furthermore, even if AAV manages to infect a target cell, these cells can then be attenuated by lymphocytes. Improvements in our understanding of how the immune system responds to AAV have guided engineering of the capsid to reduce those responses, yielding capsid variants that are much stealthier and more effective. This review summarizes recent advances in understanding the immune response to AAV as well as highlights engineering methods that enhance AAV's potential as a gene therapy vector.

59 BASIC BIOLOGICAL SCIENCES↗

Engineering the Interface Between Inorganic Materials and Cells

To further optimize cell function in hybrid “living materials”, it would be advantageous to render mammalian cells responsive to novel “orthogonal” cues, i.e. signals they would not ordinarily respond to but that can be engineered to feed into defined intracellular signaling pathways. We recently developed an optogenetic method, based on A. thaliana Cry2, for rapid and reversible protein oligomerization in response to blue light. We also demonstrated the ability to use this method to channel the light input into several defined signaling pathways, work that will enhance communication between inorganic devices and living systems.

36 MATERIALS SCIENCE↗